Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Auteurs

Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL

  • Date de publication

    May 2024

  • Type

    Article

  • Review

    Eur J Cancer

  • Researcher's name

    Navez Julie

  • Hôpital

    Hôpital Erasme

  • Service

    Chirurgie digestive

  • PMID

    38805957

  • DOI

    10.1016/j.ejca.2024.114128